Oxelumab

From Wikipedia, the free encyclopedia
Oxelumab ?
Monoclonal antibody
Type Whole antibody
Source Human
Target OX-40 ligand
Clinical data
Legal status ?
Identifiers
CAS number 1186098-83-8 N
ATC code None
Chemical data
Formula C6424H9920N1704O2014S42 
Mol. mass 144.6 kDa
 N (what is this?)  (verify)

Oxelumab is a human monoclonal antibody designed for the treatment of asthma.[1]

Oxelumab was developed by Genentech and co-developed by Roche.

References

  1. "Statement On A Nonproprietary Name Adopted By The USAN Council: Oxelumab". American Medical Association. 


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.